Targeting the $5 BILLION Soft Tissue Repair Market

Chitogenx is in the regulatory lead for regenerative products + signs MOU with major Medical Institute

Free
Message: SmallCap 60: Ortho Regenerative Technologies (ORTH: CSE) (ORTIF: OTCQB) Believes It Has Found The Solution To A Multi-Billion Dollar Problem

SmallCap 60: Ortho Regenerative Technologies (ORTH: CSE) (ORTIF: OTCQB) Believes It Has Found The Solution To A Multi-Billion Dollar Problem

posted on Apr 18, 2022 02:22PM

Share
New Message
Please login to post a reply